Bronchiectasis, formally known as non-cystic fibrosis bronchiectasis, is the dilation of the small airways resulting in persistent cough, sputum production and recurrent chest infection, and develops as a result of insult and damage to the airways. The disease is more common in women than men and has an increasing incidence and prevalence. Early recognition of the signs and symptoms of bronchiectasis will support prompt investigations and management to reduce disease progression. This article gives an overview of bronchiectasis, its causes, treatment and management. It also discusses the role of general practice nurses (GPNs) in identifying and treating patients with the condition.
The 21st September 2016 saw the launch of the latest version of our national asthma guideline, published jointly by the British Thoracic Society and the Scottish Intercollegiate Guidelines Network (BTS/SIGN, 2016).
The original BTS guideline was published in 1990, and SIGN’s own version dated back to 1996. In 1999 the two organisations recognised the need to develop a joint guideline, the result of which was the 2003 BTS/SIGN asthma guideline (SIGN/BTS, 2011).
This is the seventh version of this guideline, which has been produced in conjunction with a range of stakeholders including the Royal College of Physicians (RCP), Primary Care Respiratory Society (PCRS), Asthma UK and Health Improvement Scotland (HIS).
Success!